Clinical Gastroenterology and Hepatology

Article	Citations
Editorial Board	487
Front Cover	347
Hepatic Artery Pseudoaneurysm After Whipple Procedure	267
Table of Contents	257
Blue Notes	218
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?	209
Fecal Microbiota-based Therapies Compared to Fecal Microbiota Transplantation for Preventing Recurrent C. difficile Infection	207
Assessment and Significance of Histologic Activity in Crohn’s Disease	188
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?	186
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial	183
Reply	174
Blue Notes	166
FODMAPs in IBS: Revisiting Restriction	165
Editorial Board	163
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion	163
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA	156
Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study	153
Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis	143
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study	142
Elsewhere in the AGA Journals	140
Reply	131
Correction	130
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants	129
Editorial Board	126
Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling	125

Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?	121
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis	119
Elsewhere in the AGA Journals	116
Gut Microbiome Modulation by Antibiotics in Adult Asthma: A Human Proof-of-Concept Intervention Trial	116
Reply	112
A Case of Pedunculated Esophageal Neuroendocrine Tumor G1	110
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study	109
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials	109
Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study	108
Endoscopic Polypectomy: How Should We Determine Complete Resection Status?	104
Reply	104
Issue Highlights	104
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum	103
Attribution of Colonoscopy Risk Does Not FIT!	103
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward	102
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia	101
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability	100
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease	99
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels	99
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis	99
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease	95
Associations Between Sexual Orientation and Disorders of Gut-brain Interaction in Sexual Minority Populations	95
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study	95
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome	95
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study	93
AI-Assisted Capsule Endoscopy for Detection of Ulcers and Erosions in Crohn’s Disease: A Multicenter Validation Study	92
Barrett’s Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study	91
The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy	90
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis	90
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn’s Disease	89
Chronic kidney disease does not influence response to terlipressin in hepatorenal syndrome – acute kidney injury	85
Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis	84
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States	83
Perianal Disease in Pediatric-onset Crohn’s Disease: Incidence, Disease Course, and Long-term Outcomes	81
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction	80
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy	80
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial	80
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission	79
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States	78
National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States	78
AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus: Expert Review	76
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn’s Disease: A Systematic Review and Meta-analysis	76
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary	75
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis	74
Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population	74
Update in the Treatment of the Complications of Cirrhosis	73
Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease	73
Who Examines the Colon Matters More Than What Is Removed	72
Blue Notes	72
Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist	72

Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment	72
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease	72
Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study	71
Relationship Between Gastric Emptying Rate and Simultaneously Assessed Symptoms in Functional Dyspepsia	70
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort	70
Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-controlled Randomized Trial	70
Table of Contents	69
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions	69
Blue Notes	68
Reply	67
Editorial Board	67
Front Cover	66
Harm-to-Benefit Ratio of Fecal Immunochemical Test–Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations	66
Acute-onset Type 1 Diabetes Mellitus and Pancreatic Atrophy Caused by an Immune Checkpoint Inhibitor	66
Continuing the Commitment to Diversity, Equity, and Inclusion Within AGA Journals	66
Bouveret Syndrome Treated With Endoscopic Lithotripsy and Gallbladder Access via Cholecysto-duodenal Fistula	65
Risk of Advanced Colorectal Neoplasia at Follow-up Colonoscopy After Synchronous Adenoma and Clinically Significant Serrated Polyp	63
Response to “Recent Advancements and Future Perspectives of Per Oral Endoscopic Myotomy”	63
Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis	63
Skills or Pills: Randomized Trial Comparing Hypnotherapy to Medical Treatment in Children With Functional Nausea	62
Prolonged Gastrointestinal Manifestations After Recovery From COVID-19	62
Primary Sclerosing Cholangitis–Associated Pouchitis: A Distinct Clinical Phenotype	62
The EXTENT Study: Results From an International Expert Delphi Consensus to Define Ultrasonographic Parameters for Measuring Bowel Damage in Crohn’s Disease	61
Personalized (N-of-1) Clinical Trials for Inflammatory Bowel Disease: Opportunities and Challenges	61
Real-world Comparison of Steatosis-Associated Fibrosis Estimator and Fibrosis-4 Scores for Assessing Metabolic Dysfunction-associated Steatotic Liver Disease-related Fibrosis in a Highly Diverse Urban	61
Significance of Crypt Atypia in Barrett’s Esophagus: A Clinical, Molecular, and Outcome Study	61
Two vs One Forward View Examination of Right Colon on Adenoma Detection: An International Multicenter Randomized Trial	60
Mental Health Diseases Are Associated With Active Hepatitis C and Partly Drive Hepatocellular Carcinoma Trends in Veterans	60
Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome	60
Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis	59
The Severity of Reduced Esophageal Distensibility Parallels Eosinophilic Esophagitis Disease Duration	59
Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 Persons	59
Avoidant Restrictive Food Intake Disorder Prevalent Among Patients With Inflammatory Bowel Disease	59
Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies	59
The Affordable Care Act Improves Access, Survival, and Racial Disparities of Patients With Liver Disease: A Systematic Review	58
Needle Track Seeding After Trans-gastric EUS-guided Tissue Sampling: Maybe Not as Rare as You Think	58
Diet and Microbiome-Directed Therapy 2.0 for IBD	58
Reply	58
Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps	57
An Unusual Complication of Endoscopic Ultrasound-guided Transgastric Liver Biopsy	56
Multiple Negative Fecal Immunochemical Tests: Is Testing Really Better?	56
Environmental Toxins in Breast Milk and Risk of Early Onset Colorectal Cancer	56
Reply	56
Gastroparesis and Chronic Pancreatitis: Are They Truly Related?	56
Value of Ammonia Testing in Clinical Practice	55
Distinctive Clinical Correlates of Small Intestinal Bacterial Overgrowth with Methanogens	55
Health Policy Priorities for the Biden Administration	55
Preoperative Hepatology and Primary Care Visits Improve Postoperative Outcomes in Patients With Cirrhosis Undergoing Surgery	55
Editorial Board	54
Direct Oral Anticoagulants in Budd-Chiari Syndrome: Need a Closer Look!	54
Uptake of Colorectal Cancer Screening in 45 to 49 Year Olds: An Early-Inning View from the Endoscopy Suite	54
Unusual Presentation of a Crohn’s Disease Patient: Not Your Typical Flare	54
Von Willebrand Factor Level Indicate Response to β-Blockers in Cirrhosis: Need a Closer Look!	53
Reply	53
Transient Uterine Prolapse: A Rare Complication of Endoscopic Polypectomy	53
The New Kids on the Block: Emerging Complementary Colonoscopy Quality Metrics	53
Information for Authors and Readers	53
Cover	53
Reply	53
Editorial Board	53
Reply	53
Reply	53
Cover	52
A Framework for Creating a FOAMed Organization in Gastroenterology: Lessons Learned from the Liver Fellow Network	52
Correction	52
Editorial Board	52
Foaming at the Varix: Sclerotherapy of Esophageal Varices via Intrahepatic Portal Vein Access	52
Hurdles in ERCP Trials: Do We Need to Change the Diagnostic Criteria for Post-ERCP Pancreatitis?	51
Table of Contents	51
Close Observation of the Lateral Walls of the Oropharynx During Esophagogastroduodenoscopy	50
Prior Authorizations Delay Therapy, Impact Decision-making, and Lead to Adverse Events in Inflammatory Bowel Disease: 2022 Provider Survey	50
Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals	50
Statins for Chronic Liver Disease and the Need for Randomized Controlled Trials	50
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular Carcinoma	50
Reply	50
Extraintestinal Symptoms in Irritable Bowel Syndrome Are Associated With Stress Reactivity and the Gut Microbiome in a Sex-dependent Manner	50
Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network	49
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis	49
Upadacitinib in Mothers With Inflammatory Bowel Disease: Placental Transfer and Breast Milk Excretion	49
All-cause and Cause-specific Mortality in Achalasia: A Nationwide Matched Cohort Study	49

Long-Term Proton Pump Inhibitor Use: Review of Indications and Special Considerations	48
Continuous Risk Score Predicts Waitlist and Post-transplant Outcomes in Hepatocellular Carcinoma Despite Exception Changes	48
Diverticulosis Is Associated With Internal Hemorrhoids on Colonoscopy: Possible Clues to Etiology	48
Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct	47
Perianal Fistulizing Crohn’s Disease–Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus	47
North American Expert Consensus on the Post-procedural Care of Patients After Per-oral Endoscopic Myotomy Using a Delphi Process	47
Population-based Screening for Hereditary Colorectal Cancer Variants in Japan	47
Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update	47
Constrictive and Hypertrophic Strictures in Ileal Crohn’s Disease	47
Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease	46
Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis	46
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion	46
Deficits in Geriatric Assessment Associate With Disease Activity and Burden in Older Patients With Inflammatory Bowel Disease	46
Nonrecurrence Rate of Underwater EMR for ≤20-mm Nonampullary Duodenal Adenomas: A Multicenter Prospective Study (D-UEMR Study)	46
Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease	46
Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease	46
Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy	46
Editorial Board	45
Birth Cohort Colorectal Cancer (CRC): Implications for Research and Practice	45
Distinct Clinical Physiologic Phenotypes of Patients With Laryngeal Symptoms Referred for Reflux Evaluation	45
Front Cover	45
Nature and Nurture in Familial Aggregation of Steatotic Liver Disease	45
Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis	45
Colon Volume by Computed Tomography and Scintigraphic Colonic Transit in Constipated Patients With or Without Redundant Colon	45
Editorial Board	45
Reply	45
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults	45
Reply	45
Establishing an Endobariatric Practice: Steps, Challenges, and Considerations Within a Private Practice Model	44
Safety and Efficacy of Cold Snare Polypectomy Without Submucosal Injection for Large Sessile Serrated Lesions: A Prospective Study	44
Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases	44
Patient Navigation Increases Linkage to Care and Receipt of Direct-acting Antiviral Therapy in Patients with Hepatitis C	44
Declines in Colorectal Cancer Incidence and Mortality Rates Slow Among Older Adults	44
Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis	44
Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy With Inflammatory Bowel Disease: Stop the Disease, Not the Drug!	43
Diffuse Large B-Cell Duodenal Lymphoma Presenting With Obstruction and Pneumatosis	43
Depression and Anxiety Are Common Among Patients With Cirrhosis	43
AGA Clinical Practice Update on Endoscopic Lifting Agents: Commentary	43
Preparing the Next Generation of Gastroenterologists to Tackle Climate Change	43
Perceptions, Definitions, and Therapeutic Interventions for Occasional Constipation: A Rome Working Group Consensus Document	43
Elsewhere in the AGA Journals	43
Interventional Radiological Management for Budd-Chiari Syndrome: A 10-Year Retrospective, Multicenter Survey on 997 Patients in China	42
Decreasing Case Fatality Rates for Patients With Cirrhosis Infected With SARS-CoV-2: A National COVID Cohort Collaborative Study	42
Prediction of Postoperative Recurrence in Crohn’s Disease: Where Do We Go From Here?	42
Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL Study	42
Letter Response to: Hernandez-Rocha C et al, Clin Gastroenterol Hepatol 2024	42
Reply	42
Lymphangioma in a Child Managed With Debulking Surgery	41
Reply	41
Information for Authors and Readers	41
To Stop or Not to Stop? Predicting Relapse After Anti-TNF Cessation in Patients With Crohn’s Disease	41
Front Cover	41
Approach to Dietary Restriction in Irritable Bowel Syndrome	41
Reply	41
Editorial Board	41
Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma With Varices Using Red Dichromatic Imaging	40
Blue Notes	40
Reply	40
Reply	40
Elsewhere in the AGA Journals	40
Blue Notes	40
Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities	40
Adult-Onset Fontan Circuit Failure: A Rare Cause of Protein-Losing Enteropathy	39
Repeating Ultrasound for Hepatocellular Carcinoma Detection in Case of Inadequate Liver Visualization: A Matter of Expertise	39
Stratifying Risks of Ileal Pouch Outcomes	39
Reply	39
Editorial Board	39
Reply	39
Endoscopic Sedation Type During FLIP Panometry Does Not Significantly Impact FLIP Motility Classification Relative to Manometry	38
Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel Disease	38
Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis	38
Dietary Fiber is Associated With Decreased Risk of Gastroesophageal Reflux Symptoms	38
Symptom Classes in Decompensated Liver Disease	38
Effect of Exclusion Diets on Symptom Severity and the Gut Microbiota in Patients With Irritable Bowel Syndrome	38
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study	38
Baseline Hepatitis B Virus Surface Antigen Titers in Childhood Predict the Risk of Advanced Liver Fibrosis in Adulthood	38
Upadacitinib Was Efficacious and Well-tolerated Over 30 Months in Patients With Crohn’s Disease in the CELEST Extension Study	38
Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis	38
Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era	37
Crafting a Therapeutic Pyramid for Eosinophilic Esophagitis in the Age of Biologics	37
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis	37
Underestimation of Cirrhosis-Related Mortality in the Medicare Eligible Population, 1999–2018	37
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States	37
Linked-Color Imaging Detects More Colorectal Adenoma and Serrated Lesions: An International Randomized Controlled Trial	37
Abdomino-anal Dyscoordination in Defecatory Disorders	37
Table of Contents	37
Diagnosis of Retrograde Cricopharyngeus Dysfunction Using High Resolution Impedance Manometry and Comparison With Control Subjects	37
Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease	37
An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice	37
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis	37
Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease	36
Internal Hernia and Volvulus After EUS-Guided Gastrojejunostomy	36
Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases	36
Lubiprostone for Pediatric Functional Constipation: Randomized, Controlled, Double-Blind Study With Long-term Extension	36
Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis	36